Author

Year

No. of patient

Drug

PSA RR ≥ 50%

Tumor response rate%

Median PFS, mo

Median OS, mo

de Bono

2010

378

Cabazitaxel (TROPIC)

39.2

14.4

2.8

15.1

Fizazi

2012

797

Abiraterone acetate (COU-AA-301)

29.5

14.8

5.6

15.8

Scher

2012

800

Enzalutamide (AFFIRM)

54

29

8.3

18.4

Ross

2007

34

Docetaxel and carbopolatin

18

N/A

3

12.4

Loriot

2009

40

Etoposide, carboplatine with or without EMP

23

N/A

N/A

19

Sella

2009

15

Paclitaxel, estramustine, and carboplatin

60

40

4

14.6

Nozawa

2015

44

Cabazitaxel (Japanese phase I)

29.5

16.7

3.68

N/A

Current study

19

Docetaxel, estramustine phosphate and carbopolatin

31.6

10

3.7

18